These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34853083)

  • 1. Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome.
    McGregor R; Wu MF; Holmes B; Lam HA; Maidment NT; Gera J; Yamanaka A; Siegel JM
    J Neurosci; 2022 Jan; 42(2):255-263. PubMed ID: 34853083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sodium oxybate on hypocretin/orexin and locus coeruleus neurons.
    Wu MF; Thannickal TC; Li S; McGregor R; Lai YY; Siegel JM
    Sleep; 2023 Sep; 46(9):. PubMed ID: 37155728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal.
    Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    J Physiol Sci; 2019 Mar; 69(2):281-293. PubMed ID: 30406600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN.
    Benavides M; Laorden ML; García-Borrón JC; Milanés MV
    Eur J Neurosci; 2003 Jan; 17(1):103-12. PubMed ID: 12534973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.
    Foster SL; Galaj E; Karne SL; Ferré S; Weinshenker D
    Addict Biol; 2021 Sep; 26(5):e13037. PubMed ID: 33768673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pannexin-1 channel inhibition alleviates opioid withdrawal in rodents by modulating locus coeruleus to spinal cord circuitry.
    Kwok CHT; Harding EK; Burma NE; Markovic T; Massaly N; van den Hoogen NJ; Stokes-Heck S; Gambeta E; Komarek K; Yoon HJ; Navis KE; McAllister BB; Canet-Pons J; Fan C; Dalgarno R; Gorobets E; Papatzimas JW; Zhang Z; Kohro Y; Anderson CL; Thompson RJ; Derksen DJ; Morón JA; Zamponi GW; Trang T
    Nat Commun; 2024 Jul; 15(1):6264. PubMed ID: 39048565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal.
    Davoudi M; Vijeepallam K; Azizi H; Mirnajafi-Zadeh J; Semnanian S
    J Neural Transm (Vienna); 2019 Nov; 126(11):1425-1435. PubMed ID: 31493096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy.
    Thannickal TC; John J; Shan L; Swaab DF; Wu MF; Ramanathan L; McGregor R; Chew KT; Cornford M; Yamanaka A; Inutsuka A; Fronczek R; Lammers GJ; Worley PF; Siegel JM
    Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.
    Sharf R; Sarhan M; Dileone RJ
    Biol Psychiatry; 2008 Aug; 64(3):175-83. PubMed ID: 18423425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
    Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
    Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats.
    Ghaemi-Jandabi M; Azizi H; Ahmadi-Soleimani SM; Semnanian S
    Brain Res Bull; 2017 Apr; 130():107-111. PubMed ID: 28093335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
    Hooshmand B; Azizi H; Javan M; Semnanian S
    Neurosci Lett; 2017 Jan; 636():276-281. PubMed ID: 27816550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
    Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
    Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus.
    van den Pol AN; Ghosh PK; Liu RJ; Li Y; Aghajanian GK; Gao XB
    J Physiol; 2002 May; 541(Pt 1):169-85. PubMed ID: 12015428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep.
    Schwartz MD; Nguyen AT; Warrier DR; Palmerston JB; Thomas AM; Morairty SR; Neylan TC; Kilduff TS
    eNeuro; 2016; 3(2):. PubMed ID: 27022631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.
    Georgescu D; Zachariou V; Barrot M; Mieda M; Willie JT; Eisch AJ; Yanagisawa M; Nestler EJ; DiLeone RJ
    J Neurosci; 2003 Apr; 23(8):3106-11. PubMed ID: 12716916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.
    Horvath TL; Peyron C; Diano S; Ivanov A; Aston-Jones G; Kilduff TS; van Den Pol AN
    J Comp Neurol; 1999 Dec; 415(2):145-59. PubMed ID: 10545156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Levels of the Tyrosine Hydroxylase Gene and Histone Modifications Around its Promoter in the Locus Coeruleus and Ventral Tegmental Area of Rats during Forced Abstinence from Morphine.
    Jalali Mashayekhi F; Rasti M; Khoshdel Z; Owji AA
    Eur Addict Res; 2018; 24(6):304-311. PubMed ID: 30517913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal.
    Shaw-Lutchman TZ; Barrot M; Wallace T; Gilden L; Zachariou V; Impey S; Duman RS; Storm D; Nestler EJ
    J Neurosci; 2002 May; 22(9):3663-72. PubMed ID: 11978842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
    Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
    Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.